본문 바로가기

Global Center
통합검색
Search freely
누리집 안내지도

Investment News

Event Photos
  1. 홈
A land sales contract was signed to build SK Bioscience Research Institute
  • Date Created : 2022-01-14
  • Number of Views : 155
(211227)SK바이오사이언스 투자 계약 체결(8328)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8327)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8326)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8325)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8324)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8323)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8328)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8327)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8326)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8325)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8324)-3000px
(211227)SK바이오사이언스 투자 계약 체결(8323)-3000px
On December 27, 2021 (Monday), IFEZ signed a land sale contract with SK Bioscience to build a research institute in Songdo International City. SK Bioscience plans to build a vaccine R&D facility in Sr14 lot (178-3 Songdo-dong / 30,413.8㎡) of Techno Park expansion complex in Songdo International City 7, and its headquarters and research institute will be built together. SK Bioscience is said to have changed the paradigm of the domestic and foreign vaccine market based on its own R&D technology and globally recognized production capabilities, and recently played a decisive role in Korea's leap into the hub of global COVID-19 vaccine production.
List